+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06996509

Randomized Study Comparing High-Velocity Nasal Cannula and Non-Invasive Ventilation for Respiratory Support in Guillain-Barr Syndrome

Led by Assiut University · Updated on 2026-09-22

80

Participants Needed

2

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying adult patients with Guillain-Barr Syndrome GBS who experience severe breathing difficulties due to this acute autoimmune disorder that causes rapid muscle weakness. The study compares two types of non-invasive breathing support high-velocity nasal cannula HVNC, delivering heated and humidified air at 35-60 Lmin, and bi-level noninvasive ventilation NIV, which uses two levels of airway pressure. The main objective is to assess how many patients can stop using non-invasive support without needing invasive mechanical ventilation by Day 30, along with other factors such as time to stop support, patient comfort, length of hospital stay, days breathing independently, and mortality within 30 days. Participants are randomly assigned to receive either NIV, delivered via a tightly fitting mask with inspiratory and expiratory positive airway pressures IPAP 10-16 cmHO, EPAP 5-8 cmHO, or HVNC, which provides heated, humidified gas at flow rates of 35-60 Lmin with oxygen levels adjusted to maintain adequate oxygen saturation. Both treatments aim to support breathing without invasive ventilation. The study lasts up to 30 days after randomization, monitoring the duration and success of weaning from non-invasive support. During the study, patients are closely monitored daily for up to 28 days after randomization, focusing on successful weaning from respiratory support and overall health outcomes. Measurements include respiratory function, patient comfort, duration of ICU and hospital stays, and survival status. Researchers aim to maximize the time patients breathe without invasive ventilation. The study is conducted at a single center with open-label treatment allocation and includes continuous assessment of patient status throughout the study period.

CONDITIONS

Brief Title

Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome

Research Team

A

Ahmad M. Shaddad, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here